[HTML][HTML] Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW Jones, DA Mahler, R Gale, R Owen, B Kramer - Respiratory medicine, 2011 - Elsevier
BACKGROUND: Indacaterol is a novel, inhaled, ultra-long-acting β2-agonist bronchodilator
for maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
for maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW Jones, DA Mahler, R Gale, R Owen, B Kramer - 2011 - pubmed.ncbi.nlm.nih.gov
Background Indacaterol is a novel, inhaled, ultra-long-acting β (2)-agonist bronchodilator for
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
PW Jones, DA Mahler, R Gale, R Owen… - Respiratory …, 2011 - europepmc.org
Background Indacaterol is a novel, inhaled, ultra-long-acting β (2)-agonist bronchodilator for
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
[PDF][PDF] Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW Jones, DA Mahler, R Gale, R Owen… - Respiratory …, 2011 - core.ac.uk
Background: Indacaterol is a novel, inhaled, ultra-long-acting b2-agonist bronchodilator for
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW Jones, DA Mahler, R Gale, R Owen, B Kramer - Respiratory Medicine, 2011 - infona.pl
Indacaterol is a novel, inhaled, ultra-long-acting β 2-agonist bronchodilator for maintenance
use in patients with COPD. The aim of this paper is to assess the effect of indacaterol on …
use in patients with COPD. The aim of this paper is to assess the effect of indacaterol on …
[HTML][HTML] Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW Jones, DA Mahler, R Gale, R Owen… - Respiratory …, 2011 - resmedjournal.com
Background Indacaterol is a novel, inhaled, ultra-long-acting β 2-agonist bronchodilator for
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
maintenance use in patients with COPD. The aim of this paper is to assess the effect of …
[引用][C] Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
PW JONES, DA MAHLER, R GALE… - Respiratory …, 2011 - pascal-francis.inist.fr
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …